These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28592717)

  • 41. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.
    Ji XF; Fan YC; Gao S; Yang Y; Zhang JJ; Wang K
    World J Gastroenterol; 2014 Apr; 20(16):4723-9. PubMed ID: 24782625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of combined circulating TERT promoter mutations and miR-122 expression for screening HBV-related hepatocellular carcinoma.
    Trung NT; Hoan NX; Trung PQ; Binh MT; Van Tong H; Toan NL; Bang MH; Song LH
    Sci Rep; 2020 May; 10(1):8181. PubMed ID: 32424223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
    Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
    Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
    Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X
    Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
    Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
    Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
    Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
    BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
    Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum ApoB/ApoA1 ratio in patients with CHB and the occurrence of HBV related cirrhosis and HBV related hepatocellular carcinoma.
    Cai X; Peng S; Xiao X; Huang Z; Zhang P
    Sci Rep; 2024 May; 14(1):10996. PubMed ID: 38744926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
    Yang B; Guo M; Herman JG; Clark DP
    Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA LINC01793 as a potential diagnostic biomarker of hepatitis B virus-related hepatocellular carcinoma.
    Mo C; Wu J; Sui J; Deng Y; Li M; Cao Z; Hu Z; Huang J; Li S
    Clin Biochem; 2022 Oct; 108():56-62. PubMed ID: 35760369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma.
    Seo SI; Kim HS; Kim WJ; Shin WG; Kim DJ; Kim KH; Jang MK; Lee JH; Kim JS; Kim HY; Kim DJ; Lee MS; Park CK
    World J Gastroenterol; 2015 Apr; 21(13):3928-35. PubMed ID: 25852278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level.
    Ren J; He W; Zhang R; Li Z; Cao W; Yao J; Zhu F; Zhang T; Wu G
    J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):309-12. PubMed ID: 19513612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV-related liver diseases.
    Sun L; Li K; Liu G; Xu Y; Zhang A; Lin D; Zhang H; Zhao X; Jin B; Li N; Zhang Y
    Cancer Med; 2018 Oct; 7(10):5178-5186. PubMed ID: 30259695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
    Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu R; Li BZ; Li H; Ling YQ; Hu XQ; Zhai WR; Zhu HG
    Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promoter Methylation Status of Two Novel Human Genes, UBE2Q1 and UBE2Q2, in Colorectal Cancer: a New Finding in Iranian Patients.
    Mokarram P; Shakiba-Jam F; Kavousipour S; Sarabi MM; Seghatoleslam A
    Asian Pac J Cancer Prev; 2015; 16(18):8247-52. PubMed ID: 26745068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
    Li L; Guo Z; Wang J; Mao Y; Gao Q
    Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma.
    Chang R; Wei L; Lu Y; Cui X; Lu C; Liu L; Jiang D; Xiong Y; Wang G; Wan C; Qian H
    J Mol Histol; 2015 Feb; 46(1):45-56. PubMed ID: 25311764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.